Triple gastrointestinal prophylactic therapy following high-power short-duration posterior left atrial wall ablation

Candemir, Başar; Baskovski, Emir; Mammadov, Mammad; Esenboğa, Kerim; Altın, Timuçin

doi:10.1016/j.ihj.2020.06.007

Cited by 2 publications

(2 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We have very seldomly observed dyspeptic concerns, and we did not encounter any serious complications. 10 Steam-pop occurred only at 1 instance during a long-lasting RF application at LA septum with no consequence. Although esophageal temperature monitoring is not routinely recommended during ablation with conventional energy settings, this may not apply to HPSD settings although it has not been tested.…”

Section: Discussionmentioning

confidence: 97%

See 1 more Smart Citation

Long-Term Results of Pulmonary Vein Isolation Plus Modified Posterior Wall Debulking Utilizing High-Power Short-Duration Strategy: An All-Comers Study in Real World

Candemir¹,

Baskovski²,

Beton³

et al. 2022

Anatolian J Cardiol

Self Cite

View full text Add to dashboard Cite

Background: High-power short-duration radiofrequency ablation has improved lesion durability in pulmonary vein isolation. In this study, we investigate long-term clinical outcomes of high-power short-duration pulmonary vein isolation and posterior wall debulking as an initial treatment modality in all corner atrial fibrillation patients. Methods: This is a single-center, retrospective, observational study including all patients who have undergone high-power short-duration pulmonary vein and posterior wall debulking, regardless of atrial fibrillation type and/or duration. High-power short-duration power delivery protocol was defined as 45 W at all ablation sites. Clinical and electrocardiographic follow-up were performed in all patients. Results: One hundred forty-two patients were enrolled in this study. Paroxysmal atrial fibrillation was present in 88 (62%) of patients. The mean follow-up of this study was 36.9 months ± 12.2 months. During the follow-up period, 10 patients (11.4%) with a diagnosis of paroxysmal atrial fibrillation had recurrence, while recurrence in patients with persistent and long-standing persistent atrial fibrillation was slightly higher (15 patients (28.1%) and 5 patients (50%), respectively). No major life-threatening complications occurred. Conclusion: This study has demonstrated excellent arrhythmia-free outcomes in unselected, real world atrial fibrillation patients undergoing high-power short-duration pulmonary vein and debulking posterior wall isolations, however larger randomized trials are warranted.

show abstract

Section: Discussionmentioning

confidence: 97%

“…All patients received a prophylactic gastrointestinal regimen consisting of proton-pump inhibitor, sucralfate and colchicine as described by our group in a previous report. 10 …”

Section: Methodsmentioning

confidence: 99%